RxDoctor Payments DataLook up a doctor →

David Staskin

Urology · Brighton, MANPI 1629165717

Payments from drug & device makers

$806,986in general payments, 2019–2025

Across 547 payments — averaging $1475.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$373K
  • Urovant Sciences Inc$326K
  • Astellas Pharma US Inc$62K
  • Ferring Pharmaceuticals Inc.$19K
  • Laborie Medical Technologies Corp.$10K
  • E.r. Squibb & Sons, L.L.C.$8K
  • plus $9K from 15 others
$40,742in research payments, 2019–2025

Across 95 payments — averaging $428.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astellas Pharma Global Development$41K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$806,986 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.

See all urology providers in Massachusetts

Other urology in Brighton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →